Detecting the activity of antibodies induced by recombinant TGFbeta1 vaccine / 中华肝脏病杂志
Zhonghua ganzangbing zazhi
; Zhonghua ganzangbing zazhi;(12): 183-186, 2006.
Article
en Zh
| WPRIM
| ID: wpr-245714
Biblioteca responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To measure the neutralization activity in vitro of the antibodies induced by recombinant TGFbeta1 vaccine and to evaluate the vaccine's anti-liver fibrosis activity.</p><p><b>METHODS</b>Balb/c mice were immunized with a fusion protein of the human TGFbeta1 epitope-inserted into a hepatitis B core antigen using a prokaryotic expression system. The antibody produced by the recombinant vaccine was determined using ELISA. The biological activity of the anti-TGFbeta1 antibody induced by the vaccine was measured by MTT using mink lung epithelial cell Mv-1-Lu as inhibiting cells. The fusion protein was used as a vaccine in a mice hepatic-fibrosis model.</p><p><b>RESULTS</b>A high titer of anti-TGFbeta1 antibody and a low of anti-HBc antibody were detected in the mice after the immunization. The serum antibodies induced combined with the fusion and antigenic peptide prevented the TGFbeta1 inhibiting activity in the Mv-1-Lu cell.</p><p><b>CONCLUSION</b>Recombinant fusion protein can be used as a cytokine vaccine to induce high titers of anti-TGFbeta1 antibodies. Our results show the potentiality of the fusion protein to be used as a vaccine for preventing liver fibrosis.</p>
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Células Procariotas
/
Sangre
/
Proteínas Recombinantes de Fusión
/
Tetracloruro de Carbono
/
Intoxicación por Tetracloruro de Carbono
/
Vacunas Sintéticas
/
Distribución Aleatoria
/
Usos Terapéuticos
/
Alergia e Inmunología
/
Factor de Crecimiento Transformador beta1
Tipo de estudio:
Prognostic_studies
Límite:
Animals
Idioma:
Zh
Revista:
Zhonghua ganzangbing zazhi
Año:
2006
Tipo del documento:
Article